| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2006 | US6982260 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982257 1,25-dihydroxy-2-methylvitamin D3 derivatives; reacting 3,5-bis(t-butyldimethylsilyloxy)-4-methyl-1-octen-7-yne with an exo-methylene compound; treating osteoporosis |
| 01/03/2006 | US6982256 Containing cyclodextrin to improve local tolerance of the intravenously administered guanidine derivative |
| 01/03/2006 | US6982255 Comprises coadministration of galactomannan and chemotherapeutic agent (adriamycin) |
| 01/03/2006 | US6982254 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982252 Inhibition of vacuolar proton ATPase activity and/or the modulation of acidic organelle function sensitizes cells to radiation, chemotherapy and biological agents |
| 01/03/2006 | US6982251 As cholesterol-lowering agent and a cholesterol biosynthesis inhibitor for therapy and prophylaxis of atherosclerosis |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 01/03/2006 | US6982099 Composition and method for smoke detoxification |
| 01/03/2006 | US6982096 Determining a therapeutic dosage of arsenic trioxide based upon the predetermined weight of the patient and administering; Leukemia; lymphomas; solid tumors; anticarcinoma and -tumor agents |
| 01/03/2006 | US6982093 Dietary fiber delivery system |
| 01/03/2006 | US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 01/03/2006 | US6982091 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/03/2006 | US6982080 Hydroxyethyl starch—containing polypeptide compositions |
| 01/03/2006 | US6982079 Administering to eye drug with vasoconstriction and carrier |
| 01/03/2006 | US6982075 Administering a pulmonary surfactant preparation, including a phosphatide and/or a surfactant protein to artificially respirate a patient suffering from a toxic oxygen concentration; side effect reduction |
| 01/03/2006 | CA2359476C Hypolipidemic and antioxidant morpholine derivatives |
| 01/03/2006 | CA2345818C Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2339992C Orally disintegrable tablet forming a viscous slurry |
| 01/03/2006 | CA2329005C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/03/2006 | CA2264901C Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 01/03/2006 | CA2253635C Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2244773C Tropane-derivatives, their preparation and use |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 01/03/2006 | CA2243824C Therapeutic agent for keratoconjunctiva diseases |
| 01/03/2006 | CA2237897C 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols |
| 01/03/2006 | CA2235747C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 01/03/2006 | CA2203379C Cgmp-pde inhibitors for the treatment of erectile dysfunction |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 01/03/2006 | CA2187146C 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]- diazepines and their use in the prevention or treatment of hiv infection |
| 01/03/2006 | CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents |
| 01/03/2006 | CA2183083C Drug-containing adhesive composite transdermal delivery device |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2162586C Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 01/03/2006 | CA2162463C Azolylamine derivative |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 01/03/2006 | CA2153572C Transdermal therapeutic system with galanthamine as active ingredient |
| 01/03/2006 | CA2138974C Dermatological agent for aiding oxygen transport in the skin |
| 01/03/2006 | CA2136622C Phosphotriester-type biologically active compounds |
| 01/03/2006 | CA2135852C 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4t) |
| 01/03/2006 | CA2135708C Vitamin d3 analogs |
| 01/03/2006 | CA2132297C Pyrido[2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors |
| 01/03/2006 | CA2117651C Itraconazole and saperconazole stereoisomers |
| 01/03/2006 | CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids |
| 01/03/2006 | CA2070979C Sequence specific dna binding by p53 |
| 01/02/2006 | CA2571323A1 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 01/01/2006 | CA2512493A1 Methods for assessing and treating cancer |
| 01/01/2006 | CA2502425A1 Allergen from house-dust mites |
| 12/30/2005 | CA2511084A1 Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications |
| 12/30/2005 | CA2510985A1 Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same |
| 12/29/2005 | WO2005124343A2 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 12/29/2005 | WO2005124230A1 Photochromic material comprising a proteorhodopsin apoprotein and retinal analog |
| 12/29/2005 | WO2005123965A1 Potent and selective inhibition by aurintricarboxylic acid |
| 12/29/2005 | WO2005123933A1 Enzymatic deacetylation of a phenoxy-alkynyl acetate |
| 12/29/2005 | WO2005123772A2 Anti-cancer therapy |
| 12/29/2005 | WO2005123757A1 Estrogen receptor modulators |
| 12/29/2005 | WO2005123745A1 Tricyclic compounds |
| 12/29/2005 | WO2005123741A1 Alkyl substituted indoloquinoxalines |
| 12/29/2005 | WO2005123736A1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 12/29/2005 | WO2005123735A1 Process for producing evodiamine-containing composition |
| 12/29/2005 | WO2005123732A1 1-aza-bicyclo[3.3.1]nonanes |
| 12/29/2005 | WO2005123730A1 Amino-halogen-imidazopyridines as proton pump inhibitors |
| 12/29/2005 | WO2005123729A1 Lewis acid mediated synthesis of cyclic esters |
| 12/29/2005 | WO2005123728A1 Novel 9-aza-bicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123725A1 Novel compound having lipase inhibitory activity |
| 12/29/2005 | WO2005123723A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 12/29/2005 | WO2005123721A2 Amorphous and polymorphic forms of candesartan cilexetil |
| 12/29/2005 | WO2005123720A1 Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof |
| 12/29/2005 | WO2005123719A1 Compounds and compositions as protein kinase inhibitors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123717A1 7-pyrazolylbenzazepines having affinity for d3 receptor |
| 12/29/2005 | WO2005123715A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123714A1 Quinazoline compounds and their use in mch-related disease |
| 12/29/2005 | WO2005123711A1 Bicyclol glycosides and the preparation method and uses thereof |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123702A1 Neutral endopeptidase inhibitor polymorph |
| 12/29/2005 | WO2005123700A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123694A2 Quinazolinone compounds for the treatment of cough |
| 12/29/2005 | WO2005123691A1 Novel cis-imidazolines |
| 12/29/2005 | WO2005123688A2 3-aminoindazoles |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123681A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 12/29/2005 | WO2005123680A1 Six-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005123679A2 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123677A1 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents |
| 12/29/2005 | WO2005123675A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123674A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123673A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123670A2 Crystalline form of a substituted pyrrolidine compound |
| 12/29/2005 | WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/29/2005 | WO2005123666A1 Vanilloid trpv1 receptor antagonists |